Verdence Capital Advisors’s Zivo Bioscience, Inc. Warrants ZIVOW Stock Holding History

Verdence Capital Advisors’s Portfolio ZIVOW Stock Details ZIVOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-10,000	Closed	-$4.48K	–	606
2023 Q3	$4.48K	Hold	10,000	–	–	﹤0.01%	558
2023 Q2	$6K	Hold	10,000	–	–	﹤0.01%	533
2023 Q1	$5.83K	Hold	10,000	–	–	﹤0.01%	537
2022 Q4	$701	Hold	10,000	–	–	﹤0.01%	496
2022 Q3	$6K	Hold	10,000	–	–	﹤0.01%	517
2022 Q2	$4K	Hold	10,000	–	–	﹤0.01%	509
2022 Q1	$6K	Hold	10,000	–	–	﹤0.01%	510
2021 Q4	$9K	Hold	10,000	–	–	﹤0.01%	505
2021 Q3	$10K	Buy	+10,000	New	+$11.4K	﹤0.01%	493

Verdence Capital Advisors's ZIVOW Position: Q4 2023 in Review

Verdence Capital Advisors sold out of Zivo Bioscience, Inc. Warrants (ZIVOW) in Q4 2023, closing a stake of 10,000 shares — an estimated $4.48K sold.

Verdence Capital Advisors first reported a position in ZIVOW in Q3 2021 and held it in 9 quarters. The position peaked at $10K in Q3 2021. 0 funds tracked by Wall St. Rank hold ZIVOW as of Q4 2023.

Verdence Capital Advisors reported no remaining Zivo Bioscience, Inc. Warrants position as of Q4 2023 after selling out during the quarter.
Verdence Capital Advisors sold 10,000 Zivo Bioscience, Inc. Warrants shares in Q4 2023, an estimated $4.48K.
Verdence Capital Advisors first reported a position in Zivo Bioscience, Inc. Warrants in Q3 2021 and held it in 9 quarters.
Verdence Capital Advisors's Zivo Bioscience, Inc. Warrants position peaked at $10K in Q3 2021.
0 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Warrants as of Q4 2023.

Based on Verdence Capital Advisors's 13F filing for Q4 2023, filed 1 Feb 2024.